676 related articles for article (PubMed ID: 10859769)
1. [Plasmocytic pleural effusion disclosing multiple myeloma].
Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
[TBL] [Abstract][Full Text] [Related]
2. [Pleural effusion as a first sign of Ig D lambda multiple myeloma].
Maachi M; Fellahi S; Diop ME; Francois T; Capeau J; Bastard JP
Ann Med Interne (Paris); 2003 Feb; 154(1):70-2. PubMed ID: 12746663
[TBL] [Abstract][Full Text] [Related]
3. Myelomatous effusion with poor response to chemotherapy.
Kim YM; Lee KK; Oh HS; Park SK; Won JH; Hong DS; Park HS; Park JS; Lee DW
J Korean Med Sci; 2000 Apr; 15(2):243-6. PubMed ID: 10803706
[TBL] [Abstract][Full Text] [Related]
4. Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.
Pileri A; Barbui T; Boccadoro M; Comotti B; Dammacco F; Gallamini A; Marmont F; Neretto G; Petrucci MT; Resegotti L
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():168-9. PubMed ID: 2713554
[No Abstract] [Full Text] [Related]
5. Pleural and pericardial effusion as the first sign of multiple myeloma.
André M; Ponsonnaille J; Kemeny JL; Filaire M; Travade P; Aumaitre O
Ann Med Interne (Paris); 1999 Sep; 150(5):443-5. PubMed ID: 10544757
[TBL] [Abstract][Full Text] [Related]
6. [A case of aggressive myeloma with abnormal plasmocytes in pleural effusion and cerebrospinal fluid].
Sekikawa T; Iwase S; Kawano T; Takahara S; Ito K; Yamada J; Yamazaki Y; Yamada H
Rinsho Ketsueki; 1999 Jan; 40(1):22-7. PubMed ID: 10067092
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary and pleural manifestations of multiple myeloma].
Schelle M; Schreiber C; Knolle J; Florschütz A; Kachel R; Schreiber J
Pneumologie; 2006 Dec; 60(12):743-8. PubMed ID: 17163315
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic plasmapheresis in patients with multiple myeloma].
Mendek-Czajkowska E; Kraj M; Pogłód R; Rostkowska J; Maj S; Sabliński J
Acta Haematol Pol; 1991; 22(1):31-41. PubMed ID: 1823964
[TBL] [Abstract][Full Text] [Related]
9. Myeloma with pleural involvement.
Chen LM; Hwang WS
Acta Cytol; 1991; 35(3):372-3. PubMed ID: 2042441
[No Abstract] [Full Text] [Related]
10. Pleural effusion as the first sign of multiple myeloma.
Uskül BT; Türker H; Emre Turan F; Unal Bayraktar O; Melikoğlu A; Tahaoğlu C; Oz B
Tuberk Toraks; 2008; 56(4):439-42. PubMed ID: 19123081
[TBL] [Abstract][Full Text] [Related]
11. [Intracytoplasmic crystals and Fanconi syndrome in a patient with IgA kappa myeloma].
Martín Reyes G; García González I; Alférez MJ; Martínez González JM; Frutos MA
Nefrologia; 2001; 21(2):213-6. PubMed ID: 11464657
[TBL] [Abstract][Full Text] [Related]
12. [IgG-lambda-type multiple myeloma with plasma-cell pericardial effusion and terminal plasma-cell leukemia].
Klug S; Höltermann F; Fritsch H
Dtsch Med Wochenschr; 1992 Jun; 117(23):900-4. PubMed ID: 1597118
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of plasma-cell immunophenotype in patients with multiple myeloma.
Sakalová A; Holománová D; Mikulecký M; Mistrík M; Lipsic T; Steruská M
Neoplasma; 1993; 40(6):351-4. PubMed ID: 8289966
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy MOCCA in resistant and relapsing multiple myeloma. Finnish Leukaemia Group.
Eur J Haematol; 1992 Jan; 48(1):37-40. PubMed ID: 1730278
[TBL] [Abstract][Full Text] [Related]
15. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
de la Rubia J; Bladé J; Lahuerta JJ; Ribera JM; Martínez R; Alegre A; García-Laraña J; Fernández P; Sureda A; de Arriba F; Carrera D; Besalduch J; García Boyero R; Palomera Bernal L; Hernández MT; García PR; Pérez-Calvo J; Alcalá A; Casado LF; San Miguel J
Haematologica; 2006 May; 91(5):621-7. PubMed ID: 16627253
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and laboratory analysis of the cases of multiple myeloma with over 5-year survival time from the beginning of the antineoplastic treatment].
Kraj M; Rostkowska J; Sokołowska U; Maj S
Acta Haematol Pol; 1991; 22(1):42-7. PubMed ID: 1823966
[TBL] [Abstract][Full Text] [Related]
17. Pleural involvement in multiple myeloma.
Airoldi M; Fantasia R; Giorgetti A; Stefanetti C
Haematologica; 1986; 71(1):56-9. PubMed ID: 3084359
[No Abstract] [Full Text] [Related]
18. Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.
Vela-Ojeda J; García-Ruiz Esparza MA; Rosas-Cabral A; Padilla-González Y; García-Chávez J; Tripp-Villanueva F; Sánchez-Cortés E; Ayala-Sánchez M; García-León LD; Montiel-Cervantes L; Rubio-Borja ME
Ann Hematol; 2002 Jul; 81(7):362-7. PubMed ID: 12185504
[TBL] [Abstract][Full Text] [Related]
19. [Long-term fever and light-chain myeloma].
Gripenberg M
Duodecim; 1995; 111(4):345-7. PubMed ID: 8654302
[No Abstract] [Full Text] [Related]
20. [Multiple myeloma in a patient in remission from malignant lymphoma].
Hashimoto S; Kawano E; Hirasawa A; Morio S; Aotuka N; Nakamura H; Oh H; Itoh K; Asai T; Yoshida S
Rinsho Ketsueki; 1992 May; 33(5):671-6. PubMed ID: 1630019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
